Growing evidence suggests that patients with epidermal growth factor receptor (EGFR) gene mutation-positive NSCLC are quite prone to the development of brain metastases, with the frequency ranging from 44% to 63% [2] (Supplementary Figure 1). This evidence concerns the gene EGFR and non-small cell lung carcinoma.